GSE117620 resveratrol 1 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE117620_resveratrol_1_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE117620_resveratrol_1_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE117620_resveratrol_1_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE117620_resveratrol_1_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

Morf4 family associated protein 1 like 2

Gene

long intergenic non-protein coding RNA 2009

Gene

MSANTD2 antisense RNA 1

Gene

collagen type VI alpha 4 pseudogene 1

Gene

leukemia-associated non-coding IGF1R activator RNA 1

Gene

long intergenic non-protein coding RNA 940

Gene

elongin B pseudogene 2

Gene

OVOL1 antisense RNA 1

Gene

RPS27A pseudogene 4

Gene

ribosomal protein L7a pseudogene 14

  • Gene

    Morf4 family associated protein 1 like 2


  • Gene

    long intergenic non-protein coding RNA 2009


  • Gene

    MSANTD2 antisense RNA 1


  • Gene

    collagen type VI alpha 4 pseudogene 1


  • Gene

    leukemia-associated non-coding IGF1R activator RNA 1


  • Gene

    long intergenic non-protein coding RNA 940


  • Gene

    elongin B pseudogene 2


  • Gene

    OVOL1 antisense RNA 1


  • Gene

    RPS27A pseudogene 4


  • Gene

    ribosomal protein L7a pseudogene 14

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.